PMC:7075884 / 1315-1537 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"63","span":{"begin":79,"end":84},"obj":"Species"},{"id":"83","span":{"begin":111,"end":113},"obj":"Chemical"},{"id":"86","span":{"begin":135,"end":144},"obj":"Disease"}],"attributes":[{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"Tax:10298"},{"id":"A83","pred":"tao:has_database_id","subj":"83","obj":"MESH:C112485"},{"id":"A86","pred":"tao:has_database_id","subj":"86","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" virion entry by blocking the initial fusion event. Data showing inhibition of HSV-1 and CMV replication, when GA is administered post-infection, suggest a possible secondary mechanism targeting protein and DNA synthesis. "}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":195,"end":202},"obj":"Body_part"},{"id":"T10","span":{"begin":207,"end":210},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma74412"}],"text":" virion entry by blocking the initial fusion event. Data showing inhibition of HSV-1 and CMV replication, when GA is administered post-infection, suggest a possible secondary mechanism targeting protein and DNA synthesis. "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T7","span":{"begin":135,"end":144},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":" virion entry by blocking the initial fusion event. Data showing inhibition of HSV-1 and CMV replication, when GA is administered post-infection, suggest a possible secondary mechanism targeting protein and DNA synthesis. "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T20","span":{"begin":154,"end":155},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" virion entry by blocking the initial fusion event. Data showing inhibition of HSV-1 and CMV replication, when GA is administered post-infection, suggest a possible secondary mechanism targeting protein and DNA synthesis. "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T31","span":{"begin":111,"end":113},"obj":"Chemical"},{"id":"T34","span":{"begin":195,"end":202},"obj":"Chemical"},{"id":"T35","span":{"begin":207,"end":210},"obj":"Chemical"}],"attributes":[{"id":"A31","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_5206"},{"id":"A32","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_73855"},{"id":"A33","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_5354"},{"id":"A34","pred":"chebi_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_16991"}],"text":" virion entry by blocking the initial fusion event. Data showing inhibition of HSV-1 and CMV replication, when GA is administered post-infection, suggest a possible secondary mechanism targeting protein and DNA synthesis. "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T11","span":{"begin":207,"end":220},"obj":"http://purl.obolibrary.org/obo/GO_0071897"},{"id":"T12","span":{"begin":211,"end":220},"obj":"http://purl.obolibrary.org/obo/GO_0009058"}],"text":" virion entry by blocking the initial fusion event. Data showing inhibition of HSV-1 and CMV replication, when GA is administered post-infection, suggest a possible secondary mechanism targeting protein and DNA synthesis. "}

{"project":"LitCovid-sentences","denotations":[{"id":"T12","span":{"begin":52,"end":221},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" virion entry by blocking the initial fusion event. Data showing inhibition of HSV-1 and CMV replication, when GA is administered post-infection, suggest a possible secondary mechanism targeting protein and DNA synthesis. "}